rac-1-([1,1'-biphenyl]-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol

ID: ALA4647396

PubChem CID: 156020829

Max Phase: Preclinical

Molecular Formula: C24H27NO4

Molecular Weight: 393.48

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccccc1OCCNCC(O)COc1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C24H27NO4/c1-27-23-9-5-6-10-24(23)28-16-15-25-17-21(26)18-29-22-13-11-20(12-14-22)19-7-3-2-4-8-19/h2-14,21,25-26H,15-18H2,1H3

Standard InChI Key:  YZGXWNKKKRJRMW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   26.5948   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5936   -3.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3085   -4.2778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0249   -3.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0221   -3.0339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3067   -2.6248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3102   -5.1006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5939   -5.5123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5934   -6.3366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3083   -6.7501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0253   -6.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0223   -5.5104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3042   -1.7998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0174   -1.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7332   -1.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7356   -2.6204    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4464   -1.3808    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1621   -1.7912    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.8754   -1.3765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5911   -1.7869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3043   -1.3723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.0200   -1.7827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0210   -2.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7359   -3.0156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4501   -2.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4449   -1.7716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7296   -1.3650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3073   -3.0191    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.3089   -3.8441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  6 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 23 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4647396

    ---

Associated Targets(Human)

SK-MEL-5 (47095 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.48Molecular Weight (Monoisotopic): 393.1940AlogP: 3.77#Rotatable Bonds: 11
Polar Surface Area: 59.95Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.74CX LogP: 3.95CX LogD: 2.60
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.49Np Likeness Score: -0.46

References

1. Chang Q, Long J, Hu L, Chen Z, Li Q, Hu G..  (2020)  Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.,  28  (9): [PMID:32216987] [10.1016/j.bmc.2020.115404]

Source